NCT02001233View on ClinicalTrials.gov

A Follow-up Study for a Phase III, Efficacy Trial in Inactivated Enterovirus Type 71 (EV71) Vaccine

CompletedOBSERVATIONAL
Enrollment

10,077

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

March 31, 2014

Study Completion Date

October 31, 2014

Conditions
Hand, Foot and Mouth Disease
Interventions
BIOLOGICAL

EV71 vaccine

inactivated vaccine (vero cell) against EV71 of 400U /0.5ml, two doses, 28 days interval

Trial Locations (3)

222100

Ganyu, Lianyungang

224300

Sheyang, Yancheng

225400

Taixing, Taizhou

All Listed Sponsors
lead

Sinovac Biotech Co., Ltd

INDUSTRY

NCT02001233 - A Follow-up Study for a Phase III, Efficacy Trial in Inactivated Enterovirus Type 71 (EV71) Vaccine | Biotech Hunter | Biotech Hunter